Fulgent Genetics (FLGT) Acquisitions (2021 - 2026)

Fulgent Genetics (FLGT) posted Acquisitions of $55.6 million for Q1 2026, up 59.11% sequentially from $34.9 million in Q4 2022.

Fulgent Genetics (FLGT) Acquisitions (2021 - 2026) Analysis & Trends

Fulgent Genetics (FLGT) has 3 years of Acquisitions data on file, last reported at $55.6 million in Q1 2026.

Quarterly Acquisitions changed N/A year-over-year to $55.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.5 million (up 159.11% YoY) and the FY2025 annual result came in at -$3.8 million, changed N/A from the prior year.
Acquisitions rose to $55.6 million in Q1 2026 per FLGT's latest filing, from $34.9 million in the prior quarter.
The five-year high for Acquisitions was $55.6 million in Q1 2026, with the low at $34.9 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	144.00 Mn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	8.87 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	37.00 Mn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	415.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	2.24 Mn
10	Fulgent Genetics	642.94 Mn	360.99 Mn	21.49 Mn	55.57 Mn

Download Data